Early research (Phase 1)Temporarily pausedNCT02354547What this trial is testingSGT-53 in Children With Refractory or Recurrent Solid TumorsWho this might be right forNeoplasm SynerGene Therapeutics, Inc. 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT04902872What this trial is testingStudy of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid TumorsWho this might be right forSolid Tumor, AdultEpithelial Ovarian CancerSmall Cell Lung Carcinoma+9 more Cybrexa Therapeutics 130
Testing effectiveness (Phase 2)Active Not RecruitingNCT06390852What this trial is testingTesting LOXO-101 as Potentially Targeted Treatment in Cancers With NTRK Genetic Changes (MATCH - Subprotocol Z1E)Who this might be right forAdvanced LymphomaAdvanced Malignant Solid NeoplasmRefractory Lymphoma+2 more National Cancer Institute (NCI) 35
Early research (Phase 1)Study completedNCT05501821What this trial is testingStudy of KBA1412 in Participants With Advanced Solid Malignant TumorsWho this might be right forAdvanced Solid Tumor Malignancy Kling Biotherapeutics B.V. 16
Early research (Phase 1)Looking for participantsNCT05791448What this trial is testingAU409 for the Treatment of Advanced Primary Liver Cancers or Solid Tumor With Liver Metastatic DiseaseWho this might be right forAdvanced CholangiocarcinomaAdvanced Hepatocellular CarcinomaAdvanced Malignant Solid Neoplasm+4 more University of Southern California 36
Testing effectiveness (Phase 2)Study completedNCT00875433What this trial is testingAfatinib (BIBW 2992) QTcF Trial in Patients With Relapsed or Refractory Solid TumoursWho this might be right forNeoplasms Boehringer Ingelheim 60
Early research (Phase 1)Study completedNCT00062049What this trial is testingInterleukin-7 in Treating Patients With Refractory Solid TumorsWho this might be right forUnspecified Adult Solid Tumor, Protocol Specific National Institutes of Health Clinical Center (CC) 30
Early research (Phase 1)Study completedNCT03406949What this trial is testingMGD009/MGA012 Combination in Relapsed/Refractory CancerWho this might be right forAdvanced Solid Tumors MacroGenics 25
Early research (Phase 1)Looking for participantsNCT05859074What this trial is testingMQ710 With and Without Pembrolizumab in People With Solid Tumor CancerWho this might be right forCutaneous Squamous Cell CarcinomaSCC - Squamous Cell CarcinomaBasal Cell Carcinoma+16 more Memorial Sloan Kettering Cancer Center 56
Early research (Phase 1)Study completedNCT00259818What this trial is testingDose Escalation Study of EM-1421 for the Treatment of Recurrent or Refractory Solid TumorsWho this might be right forCancer Erimos Pharmaceuticals 30
Early research (Phase 1)Study completedNCT00036959What this trial is testingABT-751 in Treating Young Patients With Refractory Solid TumorsWho this might be right forBrain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+6 more National Institutes of Health Clinical Center (CC) 90
Testing effectiveness (Phase 2)Study completedNCT00004078What this trial is testingIrinotecan in Treating Children With Refractory Solid TumorsWho this might be right forChildhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus TumorChildhood Craniopharyngioma+18 more Children's Oncology Group 181
Testing effectiveness (Phase 2)UnknownNCT05320640What this trial is testingStudy of Chidamide, Decitabine and Immune Checkpoint Inhibitors in R/R NHL and Advanced Solid TumorsWho this might be right forRelapsed/Refractory Non-Hodgkin LymphomaAdvanced Solid Tumors Chinese PLA General Hospital 100
Early research (Phase 1)Study completedNCT01415297What this trial is testingDose Escalation Study of NKP-1339 to Treat Advanced Solid TumorsWho this might be right forSolid Tumors Niiki Pharma Inc. 46
Early research (Phase 1)Study completedNCT03205176What this trial is testingAZD5153 in Patients With Relapsed or Refractory Solid Tumors, Including LymphomasWho this might be right forMalignant Solid TumorsLymphomaOvarian Cancer+3 more AstraZeneca 49
Early research (Phase 1)Study completedNCT00968981What this trial is testingHedgehog Pathway Inhibitor GDC-0449 in Patients With Locally Advanced or Metastatic Solid Tumors That Are Refractory to Standard Therapy or for Whom No Standard Therapy ExistsWho this might be right forSolid Cancers Genentech, Inc. 67
Early research (Phase 1)Looking for participantsNCT05892718What this trial is testingA Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in Solid or Hematological TumorsWho this might be right forAdvanced Solid TumorRefractory Non-Hodgkin Lymphoma FBD Biologics Limited 80
Not applicableNo Longer AvailableNCT05511350What this trial is testingExpanded Access Protocol for Subjects With Relapsed or Refractory Advanced Solid Tumors Receiving TJ210001Who this might be right forSolid Tumor Metastatic Cancer Advanced Cancer I-Mab Biopharma US Limited
Early research (Phase 1)Looking for participantsNCT04485013What this trial is testingTTX-080 HLA-G Antagonist in Subjects With Advanced CancersWho this might be right forCancer Tizona Therapeutics, Inc 240
Very early researchLooking for participantsNCT05166070What this trial is testingAn Exploratory Clinical Study of RD133 in Subjects With Relapsed or Refractory MSLN-Positive Solid TumorsWho this might be right forSolid Tumor The First Affiliated Hospital with Nanjing Medical University 24